Matt Correa

Matt Correa has extensive work experience in the pharmaceutical industry. Matt started their career at Celgene in 2008 as a Research Associate and progressed to roles such as Associate Scientist and Senior Associate Scientist, specializing in medicinal chemistry and drug discovery. During their time at Celgene, Matt gained expertise in complex small molecule synthesis, antibody-drug conjugate chemistry, NMR spectroscopy, HPLC, chiral chromatography, and DMPK. Matt also had experience coordinating projects with CRO employees. In 2019, Matt joined Bristol Myers Squibb, where they initially served as a Senior Associate Scientist before being promoted to Scientist. Matt worked at Bristol Myers Squibb until May 2022. Currently, Matt holds the position of Scientist II at Treeline Biosciences, starting in June 2022.

Matt Correa has a Master of Science (M.S.) degree in Chemistry from Arizona State University, which they obtained between 2006 and 2008. Prior to that, they earned a Bachelor of Science (B.S.) degree in Biochemistry from California State University San Marcos, where they attended from 1999 to 2005. Their education journey started at Mt. Carmel High School, where they completed their high school education from 1995 to 1999. No specific degree or field of study is mentioned for their high school education.